AHEAD International and German Studies: Effectiveness, Safety, and Quality of Life Outcomes in Patients with Hemophilia A Treated with Antihemophilic Factor (Recombinant) in a Real-World Setting Over 5 Years

2020 ◽  
Author(s):  
Johannes Oldenburg
Sign in / Sign up

Export Citation Format

Share Document